NCT05990621View on ClinicalTrials.gov

Anti-CD70 CAR-T Cell Injection in Patients With CD70-positive Advanced Urologic Neoplasms

PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2023

Primary Completion Date

January 31, 2026

Study Completion Date

March 31, 2026

Conditions
CD70-positive Advanced Urologic Neoplasms
Interventions
BIOLOGICAL

Anti-CD70 CAR-T cells

0.6×106/Kg ～ 5.0×106/Kg; cells will be infused intravenously.

Trial Locations (1)

Unknown

RECRUITING

Changhai Hospital, Shanghai

All Listed Sponsors
collaborator

UTC Therapeutics Inc.

INDUSTRY

lead

Changhai Hospital

OTHER